Skip to main content

Gastroenterology

At the core of IGH is Dr Graham Radford-Smith's world-leading gastroenterology clinic. Dr Radford-Smith has developed a global reputation with over three decades of clinical care and more than 15 years of research experience in the are of inflammatory bowel disease.

It is highly recommended that clients undertake an IGH Induction when they join to establish a personalised gut health plan. The Induction will provide the client with an accurate base-line situation from which IGH and the client can design a tailored gut health plan.

Uniquely, IGH can deploy numerous different strategies to achieve optimum gut health for clients, including dietary, mental health, microbiome and lifestyle modifications. Throughout the Induction, clients are offered diagnostic tests to build an evidence model for a client's personalised gut health plan.

In some cases a client’s treatment may include the latest biologic therapeutics such as Stelara (Ustekinumab), Humira (Adalimumab), or Entyvio (Vedolizumab). These drugs have been found to be particularly effective in clinical trials and offer some clients the best solution for their IBD.

IGH also uses key biomarkers of disease status alongside the clients specific needs, to monitor therapy success. IGH will coordinate and integrate various evidence-based solutions to establish stable disease.
 

Graham Radford-Smith

Graham Radford-Smith is a gastroenterologist and clinician scientist specializing in the fields of Inflammatory Bowel Diseases (IBD) and non-inflammatory gut disorders.

Graham developed the IBD centre at the Royal Brisbane and Women’s Hospital (RBWH) commencing in 1997 together with Australia’s first series of IBD specialist clinics (from 1997) and IBD nurses (from 2002).

He is an honorary group leader at the QIMR Berghofer Medical Research Institute where he works with his team in the Gut Health research group, and Associate Professor within the Faculty of Medicine, University of Queensland, Chair of the ANZ IBD consortium of clinicians, and Crohn’s Colitis Cure (a charity supporting research and clinical practice for clients with IBD).